Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BurgerFi International, Inc.BFI · Entity 87763 | Director | March 29, 2024 | April 01, 2024 |
| Pediatrix Medical Group, Inc.MD · Entity 4451 | Chief Financial Officer | June 12, 2018 | June 13, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BurgerFi International, Inc.
Report date March 29, 2024 · Filed April 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 116,279 |
Reported balance
After 2024-03-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-29 · Grant · Acquired 7,583 · Balance 116,279 F1: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. F2: On March 29, 2024, the Reporting Person was granted 7,583 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which shall vest and be settled in shares of common stock on December 31, 2024, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock.
F2: On March 29, 2024, the Reporting Person was granted 7,583 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which shall vest and be settled in shares of common stock on December 31, 2024, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control.
Pediatrix Medical Group, Inc.
Report date June 12, 2018 · Filed June 13, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,590.24 |
Reported balance
After 2018-06-12 transaction · row 1
1 source rowRow 1 · 2018-06-12 · Sale · Disposed 13,942 · Balance 100,590.24 F1: The price reported in Column 4 is a weighted average price. These shares were sold in sixteen (16) separate transactions with prices ranging from $46.40 to $46.53 for an average weighted sales price of $46.4621. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in sixteen (16) separate transactions with prices ranging from $46.40 to $46.53 for an average weighted sales price of $46.4621. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2024 Filed Apr 1, 2024 16:15 UTC | BurgerFi International, Inc. BFI · Entity 87763 | GrantRestricted Stock Units · Derivative | 7,583 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039331 · ownership.xml · derivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,279 Underlying: Common Stock · 7,583 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. F2 · kind: On March 29, 2024, the Reporting Person was granted 7,583 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which shall vest and be settled in shares of common stock on December 31, 2024, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. F2 · derivative.exercise_date: On March 29, 2024, the Reporting Person was granted 7,583 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which shall vest and be settled in shares of common stock on December 31, 2024, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. F2 · derivative.expiration_date: On March 29, 2024, the Reporting Person was granted 7,583 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which shall vest and be settled in shares of common stock on December 31, 2024, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 19:40 UTC | BurgerFi International, Inc. BFI · Entity 87763 | GrantRestricted Stock Units · Derivative | 108,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001365 · ownership.xml · derivative · entry 4 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,696 Underlying: Common Stock · 108,696 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. F4 · kind: On January 2, 2024, the Reporting Person was granted 108,696 restricted stock units under the Plan, which shall vest and be settled in shares of common stock on December 31, 2024, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. F4 · derivative.exercise_date: On January 2, 2024, the Reporting Person was granted 108,696 restricted stock units under the Plan, which shall vest and be settled in shares of common stock on December 31, 2024, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. F4 · derivative.expiration_date: On January 2, 2024, the Reporting Person was granted 108,696 restricted stock units under the Plan, which shall vest and be settled in shares of common stock on December 31, 2024, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:40 UTC | BurgerFi International, Inc. BFI · Entity 87763 | Exercise / conversionRestricted Stock Units · Derivative | 79,365 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001365 · ownership.xml · derivative · entry 3 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 79,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. F1 · kind: On January 3, 2023, the Reporting Person was granted 79,365 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan (the "Plan"), which restricted stock units vested on December 31, 2023 and will be settled in shares of common stock. F1 · derivative.exercise_date: On January 3, 2023, the Reporting Person was granted 79,365 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan (the "Plan"), which restricted stock units vested on December 31, 2023 and will be settled in shares of common stock. F1 · derivative.expiration_date: On January 3, 2023, the Reporting Person was granted 79,365 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan (the "Plan"), which restricted stock units vested on December 31, 2023 and will be settled in shares of common stock. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:40 UTC | BurgerFi International, Inc. BFI · Entity 87763 | Tax withholdingCommon Stock | 27,778 | $0.92 | $25,480.76 |
DisclosureSEC source: 0000950170-24-001365 · ownership.xml · nonDerivative · entry 2 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,105 F3 · kind: Shares disposed of represent shares withheld by the issuer to pay taxes due upon vesting of restricted stock units. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:40 UTC | BurgerFi International, Inc. BFI · Entity 87763 | Exercise / conversionCommon Stock | 79,365 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-001365 · ownership.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 3, 2023, the Reporting Person was granted 79,365 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan (the "Plan"), which restricted stock units vested on December 31, 2023 and will be settled in shares of common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 16:16 UTC | BurgerFi International, Inc. BFI · Entity 87763 | GrantRestricted Stock Units · Derivative | 79,365 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000602 · doc4.xml · derivative · entry 4 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,365 Underlying: Common Stock · 79,365 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. F4 · kind: On January 3, 2023, the Reporting Person was granted 79,365 restricted stock units under the Plan, which shall vest and be settled in shares of common stock on December 31, 2023, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. F4 · derivative.exercise_date: On January 3, 2023, the Reporting Person was granted 79,365 restricted stock units under the Plan, which shall vest and be settled in shares of common stock on December 31, 2023, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. F4 · derivative.expiration_date: On January 3, 2023, the Reporting Person was granted 79,365 restricted stock units under the Plan, which shall vest and be settled in shares of common stock on December 31, 2023, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 16:16 UTC | BurgerFi International, Inc. BFI · Entity 87763 | Exercise / conversionRestricted Stock Units · Derivative | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000602 · doc4.xml · derivative · entry 3 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,455 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. F1 · kind: On January 3, 2022, the Reporting Person was granted 26,455 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan (the "Plan"), which restricted stock units vested on December 31, 2022 and will be settled in shares of common stock. F1 · derivative.exercise_date: On January 3, 2022, the Reporting Person was granted 26,455 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan (the "Plan"), which restricted stock units vested on December 31, 2022 and will be settled in shares of common stock. F1 · derivative.expiration_date: On January 3, 2022, the Reporting Person was granted 26,455 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan (the "Plan"), which restricted stock units vested on December 31, 2022 and will be settled in shares of common stock. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 16:16 UTC | BurgerFi International, Inc. BFI · Entity 87763 | Tax withholdingCommon Stock | 7,937 | $1.26 | $10,000.62 |
DisclosureSEC source: 0000899243-23-000602 · doc4.xml · nonDerivative · entry 2 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,518 F3 · kind: Shares disposed of represent shares withheld by the issuer to pay taxes due upon vesting of restricted stock units. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 16:16 UTC | BurgerFi International, Inc. BFI · Entity 87763 | Exercise / conversionCommon Stock | 26,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-000602 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 3, 2022, the Reporting Person was granted 26,455 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan (the "Plan"), which restricted stock units vested on December 31, 2022 and will be settled in shares of common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:33 UTC | BurgerFi International, Inc. BFI · Entity 87763 | GrantRestricted Stock Units · Derivative | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-000714 · doc4.xml · derivative · entry 3 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,455 Underlying: Common Stock · 26,455 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. F3 · kind: On January 3, 2022, the Reporting Person was granted 26,455 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which shall vest and be settled in shares of common stock on December 31, 2022, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. F3 · derivative.exercise_date: On January 3, 2022, the Reporting Person was granted 26,455 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which shall vest and be settled in shares of common stock on December 31, 2022, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. F3 · derivative.expiration_date: On January 3, 2022, the Reporting Person was granted 26,455 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which shall vest and be settled in shares of common stock on December 31, 2022, subject to the Reporting Person's continuous service as a director of BurgerFi International, Inc. until such time and earlier vesting due to a change of control. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:33 UTC | BurgerFi International, Inc. BFI · Entity 87763 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-000714 · doc4.xml · derivative · entry 2 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. F1 · kind: On July 13, 2021, the Reporting Person was granted 5,000 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which restricted stock units vested on December 31, 2021 and will be settled in shares of common stock. F1 · derivative.exercise_date: On July 13, 2021, the Reporting Person was granted 5,000 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which restricted stock units vested on December 31, 2021 and will be settled in shares of common stock. F1 · derivative.expiration_date: On July 13, 2021, the Reporting Person was granted 5,000 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which restricted stock units vested on December 31, 2021 and will be settled in shares of common stock. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:33 UTC | BurgerFi International, Inc. BFI · Entity 87763 | Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-000714 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On July 13, 2021, the Reporting Person was granted 5,000 restricted stock units under the issuer's 2020 Omnibus Equity Incentive Plan, which restricted stock units vested on December 31, 2021 and will be settled in shares of common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of BurgerFi International, Inc. common stock. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 16:15 UTC | BurgerFi International, Inc. BFI · Entity 87763 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-049578 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 20:57 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 13,942 | $46.46 | $647,774.60 |
DisclosureSEC source: 0001209191-18-037504 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,590.24 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in sixteen (16) separate transactions with prices ranging from $46.40 to $46.53 for an average weighted sales price of $46.4621. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section. Read SEC document |
| June 01, 2018 Filed Jun 1, 2018 21:29 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 7,395 | $45.85 | $339,060.75 |
DisclosureSEC source: 0001209191-18-034781 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,532.24 F1 · kind: Represents 7,395 shares of common stock withheld for payment of taxes upon vesting of shares previously reported. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:55 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 40,000 | $25.14 Strike: $25.14 | $1,005,600.00 |
DisclosureSEC source: 0001209191-18-032648 · doc4.xml · derivative · entry 3 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2018-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:55 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 26,058 | $46.60 | $1,214,302.80 |
DisclosureSEC source: 0001209191-18-032648 · doc4.xml · nonDerivative · entry 2 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,927.24 F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 13,942 shares of common stock upon the net exercise of 40,000 stock options with 26,058 shares withheld for payment of the exercise price and taxes, based on the market price of Issuer's common stock at the time of the option exercise. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:55 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 40,000 | $25.14 | $1,005,600.00 |
DisclosureSEC source: 0001209191-18-032648 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,985.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:05 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 36,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015793 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,985.24 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 9,215 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:42 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 23,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037318 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,125.24 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 5,841 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. F2 · balance_after: Reflects a reduction of 3,559 in previously reported target shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment. Read SEC document |
| May 05, 2017 Filed May 8, 2017 20:29 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 7,778 | $55.82 | $434,182.74 |
DisclosureSEC source: 0001209191-17-030602 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,319.24 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in ten (10) separate transactions with prices ranging from $55.80 to $55.89 for an average weighted sales price of $55.8219. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2017 Filed Feb 17, 2017 21:36 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 15,164 | $70.01 | $1,061,605.86 |
DisclosureSEC source: 0001209191-17-012145 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,097.24 F1 · price: The price reported in Column 4 is an weighted average price. These shares were sold in seven separate transactions with prices ranging from $70.00 to $70.03 for an average weighted sales price of $70.0083. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 17, 2017 Filed Jan 17, 2017 21:41 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 10,000 | $70.95 | $709,500.00 |
DisclosureSEC source: 0001209191-17-003876 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,261.24 F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.